Drug Trial Radar · NCT05905172
Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
248
Planned (sponsor's estimate)
Start
Aug 12, 2023
Primary completion
Jun 20, 2028
Study completion Oct 20, 2028
Sponsor
- Lead sponsor
- Beijing Continent Pharmaceutical Co, Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 15, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a Phase IIIb extension trial following the "A Randomized, Double-blind, Placebo-controlled, Multicenter, Entecavir-based, Phase III Clinical Trial of Hydronidone Capsule in the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B". The main objective of this study is to evaluate the effectiveness and the safety of hydronidone capsules for long-term treatment of patients with chronic viral hepatitis B liver fibrosis.
Conditions
- Liver Fibrosis
Interventions
Hydronidone capsulesDrug
After randomization, the experimental group received hydronidone capsules three times a day, 3 capsules each time, for 5 years.
The placebo capsulesDrug
After randomization, The control group received three placebo capsules three times a day. 3 capsules each time, for 5 years.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cumulative incidence of clinical endpoint events (defined as the occurrence of any clinical endpoint event).Time frame: 5years
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Beijing youan hospital, the capital of the capital
Beijing, China · Recruiting
Tsinghua Changgeng Hospital, Beijing
Beijing, China · Recruiting
The First Affiliated Hospital of Bengbu Medical University
Bengbu, China · Recruiting
The Second Xiangya Hospital, Central South University
Changsha, China · Recruiting
Xiangya Hospital, Central South University
Changsha, China · Recruiting
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China · Recruiting
Three Gorges Hospital affiliated to Chongqing University
Chongqing, China · Recruiting
Guizhou Provincial People's Hospital
Guizhou, China · Recruiting
Hangzhou Xixi Hospital (Hangzhou Sixth People's Hospital)
Hangzhou, China · Recruiting
Henan Provincial People's Hospital
Henan, China · Recruiting
Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University
Luzhou, China · Recruiting
Nanchang Ninth Hospital (Nanchang Central Hospital)
Nanchang, China · Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, China · Recruiting
The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)
Nanjing, China · Recruiting
Ningbo Huamei Hospital, University of Chinese Academy of Sciences
Ningbo, China · Recruiting
Huashan Hospital affiliated to Fudan University
Shanghai, China · Recruiting
Shenzhen Third People's Hospital
Shenzhen, China · Recruiting
The First Affiliated Hospital of Xinxiang Medical College
Xinxiang, China · Recruiting
Yanbian University Affiliated Hospital
Yanbian, China · Recruiting
Zhenjiang Third People's Hospita
Zhenjiang, China · Recruiting
Affiliated Hospital of Zunyi Medical University
Zunyi, China · Recruiting
Beijing Ditan Hospital Capital Medical University
Beijing, Beijing Municipality, China · Recruiting
Shanghai General Hospital,Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.